Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Clinical Neurology,Pharmacology
Reference14 articles.
1. Anonymous. Rufinamide: CGP 33101, E 2080, RUF 331, Xilep. Drugs R D 2005:6:249–252.
2. McLean MJ, Schmutz M, Pozza MF, Wamil AW. Effects of rufinamide on sodium-dependent action potential firing and sodium currents of rodent central neurons. Epilepsia 2005;46(suppl 6): 375. Abstract.
3. White S, Schmutz M, Pozza MF, et al. Rufinamide (CGP 33101): a broad-spectrum anticonvulsant with excellent tolerability profile in rodents. Epilepsia 2005;46(suppl 6): 373. Abstract.
4. Brunner LA, Harrigan EP, John VA, Powell ML. Pharmacokinetics of a new anticonvulsant (CGP 33101) in epileptic male patients and healthy male subjects after single ascending oral doses of 400–1200 mg. Am J Ther 1994;1: 215–220.
5. Cardot JM, Lecaillon JB, Czendlik C, et al. The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteers. Biopharm Drug Dispos 1998;19: 259–262.
Cited by
113 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献